Cambrex Corporation is an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.

We offer a variety of technology-driven products and services for generic and branded pharmaceuticals:

  • APIs
  • Advanced intermediates
  • Drug delivery products
  • Custom development and manufacturing

Our R&D and cGMP manufacturing facilities are located in the US, Europe and India. We are committed to operating our facilities with the highest standards of:

  • Regulatory compliance
  • Environmental, health and safety guidelines

Cambrex Corporation is headquartered in East Rutherford, NJ, USA and is listed on the NYSE (CBM).